title: Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor.
authors.affiliation: Department of Immunology, Tokai University School of Medicine, Isehara, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nishimura
authors.forename: K
authors.initials: K
authors.lastname: Watanabe
authors.forename: U
authors.initials: U
authors.lastname: Lee
authors.forename: T
authors.initials: T
authors.lastname: Yahata
authors.forename: K
authors.initials: K
authors.lastname: Ando
authors.forename: M
authors.initials: M
authors.lastname: Kimura
authors.forename: Y
authors.initials: Y
authors.lastname: Hiroyama
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
authors.forename: S H
authors.initials: SH
authors.lastname: Herrmann
authors.forename: S
authors.initials: S
authors.lastname: Habu
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006131:Growth Inhibitors / Q000627:therapeutic use; D018664:Interleukin-12 / Q000627:therapeutic use*; D008223:Lymphoma / Q000276:immunology / Q000473:pathology / Q000628:therapy; D008546:Melanoma, Experimental / Q000276:immunology / Q000473:pathology / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009368:Neoplasm Transplantation; D010212:Papilloma / Q000139:chemically induced / Q000628:therapy; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D018664:Interleukin-12